Spruce Biosciences, Inc. (NASDAQ:SPRB) Given Consensus Recommendation of “Hold” by Analysts
Shares of Spruce Biosciences, Inc. (NASDAQ:SPRB – Get Free Report) have been given an average recommendation of “Hold” by the six ratings firms that are currently covering the stock, Marketbeat reports. Six investment analysts have rated the stock with a hold rating. The average 12-month target price among analysts that have issued ratings on the […]
Shares of Spruce Biosciences, Inc. (NASDAQ:SPRB – Get Free Report) have been given an average recommendation of “Hold” by the six ratings firms that are currently covering the stock, Marketbeat reports. Six investment analysts have rated the stock with a hold rating. The average 12-month target price among analysts that have issued ratings on the […]
